demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID 19 outpatients
angiotensin receptor blockers (ARBs) University of Minnesota

0 studies excluded by filtering options 2